Zantoral 30mg/ml oral solution for dogs
Zantoral 30mg/ml oral solution for dogs
Authorised
- Ranitidine
Product identification
Medicine name:
Zantoral 30mg/ml oral solution for dogs
Zantoral 30 mg/ml Lösung zum Eingeben für Hunde
Active substance:
- Ranitidine
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Ranitidine30.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA02BA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- High density polyethylene bottle 48 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.
- High density polyethylene bottle 24 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.
- High density polyethylene bottle 12 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 402623.00.00
Date of authorisation status change:
Reference member state:
-
Italy
Procedure number:
- IT/V/0141/001
Concerned member states:
-
Austria
-
Belgium
-
Germany
-
Luxembourg
-
Netherlands
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
